SSII · SS Innovations International, Inc.
$3.40
+0.06 (+1.80%)
At close · Sep 2
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These conditions raise substantial doubt about our ability to continue as a going concern.”View the 10-Q filed Aug 13, 2026
Market Cap
$682.29M
Shares
200.39M
SSII metrics
61 of 114 screener metrics currently available.
Market overview
2 metricsShare price
$3.40
Market cap
$682.29M
Price action
19 metricsPrice change (1W)
-5.9%
Price change (30D)
-15.4%
Price change (3M)
-16.7%
Price change (6M)
-30.4%
Price change (YTD)
-41.2%
Price change (1Y)
-52.3%
Trailing year
Price change (5Y)
—
52-week high
$9.98
52-week low
$3.29
Change from 52-week high
-66.5%
Change from 52-week low
+1.5%
Annualized volatility
93.4%
Beta
0.7
RSI (14D)
36.9
Price vs SMA 50
-9.2%
Price vs SMA 200
-26.0%
Avg volume (3M)
63,641
Relative volume
0.9
Average dollar volume
$237,211
Company
3 metricsSector
Healthcare
Industry
Medical Devices
Shares outstanding
200.39M
Valuation
12 metricsP / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
13.0×
reciprocal yield 7.7%
P / book
12.8
reciprocal yield 7.8%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-1.8%
Historical valuation
8 metricsP / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
—
Last earnings
2025-10-28
Profitability
9 metricsGross margin
47.6%
Operating margin
-15.8%
Trailing 12 months
Net margin
-23.7%
Gross profit (TTM)
$24.97M
Operating profit (TTM)
−$8.28M
Net income (TTM)
−$12.43M
Trailing 12 months
Diluted EPS (TTM)
$-0.06
FCF margin
—
Effective tax rate
—
Growth
11 metricsRevenue growth YoY
+39.4%
Year over year
Net income growth YoY
—
Revenue (TTM)
$52.40M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+3.2%
Year over year · more shares
Revenue CAGR (3Y)
+209.3%
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—
Quality
14 metricsReturn on equity
-23.3%
Return on assets
-12.8%
Debt / equity
—
Current ratio
2.2
EBITDA (TTM)
−$7.00M
Free cash flow (TTM)
—
Quick ratio
1.7
Interest coverage
-7.3
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$13.65M
Total assets
$96.98M
Total debt
—
Cash flow & spend
7 metricsOperating cash flow (TTM)
−$15.53M
Capital expenditures (TTM)
$2.84M
R&D (TTM)
$5.57M
SG&A (TTM)
$16.96M
Stock compensation (TTM)
$9.44M
R&D / revenue
10.6%
Stock compensation / revenue
18.0%
Ownership (13F)
3 metrics13F filers
23
13F filer change QoQ
-3
Institutional ownership
0.8%
Short interest
3 metricsShort interest
0.0%
Latest settlement · 1.6 days to cover
Days to cover
1.6d
Short-squeeze score
22 / 100
Insider activity
2 metricsNet insider buying (90D)
—
Insider-sentiment score
—
Risk flags
1 metricsGoing concern
Flagged